Liandi Li
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Oncology top 10%
- Global Cancer Incidence and Screening 8
- Cancer Risks and Factors 3
-
- Gastric Cancer Management and Outcomes 3
-
- Extracellular vesicles in disease 3
- Circular RNAs in diseases 3
-
- Helicobacter pylori-related gastroenterology studies 3
- Anesthesia and Pain Management 2
Liandi Li
35 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 350
- Renewable Energy, Sustainability and the Environment 267
- Oncology 382
- Biological Psychiatry 29
- Catalysis 56
Countries citing papers authored by Liandi Li
This map shows the geographic impact of Liandi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liandi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liandi Li more than expected).
Fields of papers citing papers by Liandi Li
This network shows the impact of papers produced by Liandi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liandi Li. The network helps show where Liandi Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liandi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2022 | 16 | |
| 5 | 2021 | 35 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 15 | |
| 8 | 2021 | 25 | |
| 9 | 2018 | 18 | |
| 10 | 2018 | 20 | |
| 11 | 2016 | 32 | |
| 12 | 2016 | 3 | |
| 13 | 2016 | 4 | |
| 14 | 2013 | 13 | |
| 15 | 2012 | 215 | |
| 16 | A Report of Cancer High Incidence Scene in China | 2009 | 6 |
| 17 | An Analysis of Lung Cancer Incidence and Mortality from 30 Cancer Registries in China,1998~2002 | 2006 | 1 |
| 18 | 2004 | 14 | |
| 19 | [1990-1992 mortality of stomach cancer in China]. | 2002 | 58 |
| 20 | 2001 | 1 |
About Liandi Li
Liandi Li is a scholar working on Biological Psychiatry, Behavioral Neuroscience, Critical Care and Intensive Care Medicine, Anesthesiology and Pain Medicine and Cancer Research, having authored 37 papers that have together received 1.6k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (8 papers), MicroRNA in disease regulation (4 papers), Cancer Risks and Factors (3 papers), Gastric Cancer Management and Outcomes (3 papers), Extracellular vesicles in disease (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Circular RNAs in diseases (3 papers) and Anesthesia and Pain Management (2 papers). The work is most often cited by research in Cancer Research (350 citations), Renewable Energy, Sustainability and the Environment (267 citations), Oncology (382 citations), Biological Psychiatry (29 citations) and Catalysis (56 citations). Liandi Li has collaborated with scholars based in China, France and Germany. Frequent co-authors include Ling Yang, Yude Chen, Donald Maxwell Parkin, Jacques Ferlay, Malte Behrens, Bei Jin, Hao Yu, Feng Peng, Hongjuan Wang and Xiaosong Zhou. Their work appears in journals such as Pharmacological Research, Human Genomics, Frontiers in Bioengineering and Biotechnology, Cancer Medicine and Shock.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.